Prevail Therapeutics
Why Robinhood?
You can watch PRVL and buy or sell other stocks, ETFs, and their options commission-free!About PRVL
Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases.
PRVL Key Statistics
Stock Snapshot
With a market cap of 787.7M, Prevail Therapeutics(PRVL) trades at $23.00. The stock has a price-to-earnings ratio of -10.03.
Prevail Therapeutics(PRVL) stock opened on 2026-04-01 at —. The price climbed to — and dipped to —.
The Prevail Therapeutics(PRVL)'s current trading volume is 0, compared to an average daily volume of 1.19M.
In the last year, Prevail Therapeutics(PRVL) shares hit a 52-week high of $23.35 and a 52-week low of $9.02.
In the last year, Prevail Therapeutics(PRVL) shares hit a 52-week high of $23.35 and a 52-week low of $9.02.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.